BiomX (PHGE)
Combines laser-radar detection with AI security command-and-control software.
Something off on this page? Send us feedback.
Supplies laser-radar threat detection and AI command-and-control software, earning through hardware projects, subscriptions, co-development, and distribution while building a defense portfolio through acquisitions.
Builds a defense, security, and critical-infrastructure portfolio around DFSL's laser-radar systems and Zorronet's AI-assisted command-and-control software. DFSL supplies sensing for UAV and ground-intruder detection, perimeter and border security, surveillance, and rail or metro track monitoring. Zorronet connects cameras, sensors, analytics, alarms, drones, and robotic assets for object recognition, event routing, and automated response.
Generates revenue through hardware and project deployments, software subscriptions, co-development with defense primes, and distribution arrangements across Israel and selected international markets. Operations depend on acquisitions and integration, customer acceptance and government procurement cycles, Israeli export permissions for controlled technology, third-party components, key personnel, and continued capital. Most subsidiaries, operations, and personnel are in Israel.
Company facts
Target rangeAs of Sep 2, 2026
Latest analyst notes
No analyst notes in the last 24 months.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $572.0K · Total debt $3.4M · Total assets $28.2M · Shareholders' equity $10.9M
- Revenue
- $332.0K
- Operating income
- −$5.4M
- Net income
- −$3.8M
No dividends on record.
| Institutions13 holders · as of Mar 31, 2026 | 1.17% | 313.0K shares | |
| Insiders2 holders · as of May 15, 2025 | 0.45% | 119.5K shares | |
| Strategic holders1 holder · as of Mar 4, 2025 | 0.49% | 131.3K shares | |
| Otherremainder | 97.89% | 26.16M shares |
26.72M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (26.72M in the company's Sep 3, 2026 report, 10.15M elsewhere); stakes use the report.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Deerfield Management Company, L.P. (Series C)Institution | 0.49% | 131,272 | 13Fas of Mar 31, 2026 |
Cystic Fibrosis FoundationStrategic | 0.49% | 131,269 | 13Gfiled Mar 4, 2025 ↗ |
Nantahala Capital Management, LLCInstitution | 0.43% | 114,795 | 13Fas of Mar 31, 2026 |
Rodney HodgesInsider | 0.39% | 103,705 | 13Gfiled May 15, 2025 ↗ |
Ikarian Capital, LLCInstitution | 0.07% | 19,473 | 13Fas of Mar 31, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
Nothing filed in the last 12 months.
- Elbit Systems
Full-spectrum counter-UAS and C4I rival in Israeli defense projects.
- RTX
Counter-UAS radar and Coyote systems rival perimeter-defense bids.
- L3Harris Technologies
Integrated counter-UAS and multi-sensor C2 rival.
- Northrop Grumman
Defense mission-management rival in unmanned surveillance and C2.
- Axon Enterprise
Dual threat in airspace security and real-time sensor-fusion platforms.
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| BiomX | $0.1406 | −0.78% | $1.4M | — | — | 4.4 | — |
| Elbit Systems | $704.27 | −0.82% | $33.23B | 53.0 | — | 3.9 | +15.9% |
| RTX | $201.10 | +0.17% | $270.60B | 35.3 | 27.3 | 2.9 | +14.5% |
| L3Harris Technologies | $264.00 | +1.01% | $48.66B | 26.4 | 21.2 | 2.1 | +8.4% |
| Northrop Grumman | $526.86 | +0.59% | $74.42B | 16.6 | 17.9 | 1.7 | +5.1% |
| Axon Enterprise | $515.00 | +1.49% | $40.86B | 210.2 | 56.5 | 12.7 | +35.3% |
| Median | 35.3 | 24.2 | 2.9 | +14.5% |